Zobrazeno 1 - 10
of 2 478
pro vyhledávání: '"Hong Chen"'
Association between alopecia areata and retinal diseases: A nationwide population-based cohort study
Autor:
Mu Hong Chen, Tzeng Ji Chen, Ying-Xiu Dai, Y.T. Chang, Sheng-Hsiang Ma, Hui-Chu Ting, Ying-Hsuan Tai
Publikováno v:
Journal of the American Academy of Dermatology. 87:771-778
Background Growing evidence has revealed abnormalities in the retinal structure of patients with alopecia areata (AA). However, the relationship between AA and retinopathy remains unclear. Objective To investigate the association between AA and retin
Autor:
Ya Mei Bai, Mu Hong Chen, Mao-Hsuan Huang, Shih-Jen Tsai, Yee-Lam E Chan, Cheng Ta Li, Tung Ping Su
Publikováno v:
Journal of Psychiatric Research. 150:346-352
Objective Suicidal behavior and different mood states of bipolar I disorder (BD) have been shown to be associated with dysregulated proinflammatory cytokines. Only a few studies have examined the association between inflammation and SB in BD, and the
Publikováno v:
Immunopharmacology and Immunotoxicology. 44:586-593
Background: Dexmedetomidine (DEX) has showed significant analgesic effects in neuropathic pain, but the underlying mechanism has remained elusive. Our present study aimed to explore the effect of DEX on hyperalgesia with the involvement of p38MAPK si
Publikováno v:
Therapies. 77:339-347
Summary Background We conducted this systematic review to clarify the efficacy and safety of benvitimod on psoriasis. Methods We searched the databases of PubMed, China National Knowledge infrastructure, Cochrane Library, Embase, Web of science to id
Autor:
Jiancang Wang, Yuechun Wen, Yingxiu Luo, Xiantao Sun, Qing Wang, Zhenyin Liu, Xunda Ji, Ziqing Gao, Yi Ding, Hong Sun, Miershalijiang Wubuli, Yuxin Xu, Jiawei Yu, Juan Ye, Shangcai Xue, Xinji Yang, Minglei Han, Song Tang, Junyang Zhao, Jingwen Ding, Hongfei Liao, Chuandi Zhou, Jianyang Gong, Yanping Han, Yishuang Xiao, Xianqun Fan, Zhang Guanghong, Yu Wu, Sha Wang, Hong Chen, Jiayan Fan, Huasheng Yang, Jianhong Liang, Lixin Mei, Jizhe Cui, Xunlun Sheng, Dan Zhu, Guo Hui-yu, Yanjin He, Wei Lu, Jing Zhang, Qing Guo, Fanglin He, Yangjun Li, Xian Wang, Li Wu, Liwen Jin, Rong Liu, Xuyang Wen, Tseden Yangkyi, Renbing Jia, Zhijun Chen, Hu Liu, Jia Tan, Fang Lu, Hongfeng Yuan, Mei Jin
Publikováno v:
American Journal of Ophthalmology. 236:193-203
To report three-decade changes of clinical characteristics, progress of treatments, and risk factors associated with mortality and enucleation in patients with retinoblastoma in China.Retrospective cohort study.This multicenter study included 2552 pa
Autor:
Kwok-Hung Chan, Kwok-Yung Yuen, Hong Chen, Shuk-Ching Wong, Vincent C.C. Cheng, Brian Pui-Chun Chan, Kelvin K. W. To, Xin Li, Lin-Lei Chen, Lu Lu
Publikováno v:
The Journal of Infection
Objectives To map travel policies implemented due to COVID-19 during 2020, and conduct a mixed-methods systematic review of health effects of such policies, and related contextual factors. Design Policy mapping and systematic review. Data sources and
Autor:
Hai Wang, Wei Huang, Xinyu Li, Ning Hu, Jiawei Wang, Leilei Qin, Hong Chen, Chen Zhao, Cheng Chen
Publikováno v:
The Journal of Arthroplasty. 37:342-346
Background Inflammatory responses in patients with active rheumatoid arthritis (RA) may lead to the current serum and synovial fluid biomarkers that misidentify chronic periprosthetic joint infection (PJI). We sought to investigate the expression of
Publikováno v:
Journal of Ovarian Research, Vol 15, Iss 1, Pp 1-13 (2022)
Journal of Ovarian Research
Journal of Ovarian Research
Background Tripartite Motif-Containing 24 (TRIM24) is a member of the tripartite motif family. TRIM24 is claimed aberrantly activated in a number of cancers, such as breast cancer, prostate cancer and lung cancer. However, the expression of TRIM24 in
Autor:
Chana Weinstock, Laleh Amiri-Kordestani, Xiao Hong Chen, Elaine Chang, Eias Zahalka, Jeanne Fourie Zirkelbach, Shenghui Tang, Amna Ibrahim, Mallorie H. Fiero, Julia A. Beaver, Kirsten B. Goldberg, Vishal Bhatnagar, Miao Zhao, Paul G. Kluetz, Richard Pazdur, Tiffany K. Ricks, Jingyu Yu, Junshan Qiu, Lijun Zhang
Publikováno v:
Clin Cancer Res
On March 10, 2021, the FDA granted regular approval to tivozanib for treatment of patients with relapsed or refractory (R/R) advanced renal cell carcinoma (RCC) following two or more prior systemic therapies. Approval was based on the TIVO-3 study, a
Publikováno v:
Journal of the Chinese Medical Association. 85:139-144
Psychiatric disorders in first-degree relatives (FDRs) often differ from the index patient's diagnosis, suggesting that there is genetic contribution to psychiatric disorders in which related cases do not all map to the same diagnosis as the index ca